All In MedTech

Device Trial Radar · NCT07911163

Clinical Health Outcomes Evaluation of Terumo Aortic Hybrid Devices

Clinical HEalth Outcomes Evaluation of Terumo Aortic Hybrid Devices

Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

May 2027

Primary completion

May 2039

Study completion May 2039

Sponsor

Lead sponsor
Vascutek Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Nov 2, 2026

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This prospective, non-interventional, study of Thoraflex Hybrid devices is part of Terumo Aortic's clinical development and Post Market Clinical Follow-Up (PMCF) plan and will provide insights into both the short- and long-term clinical outcomes of all commercially available Thoraflex Hybrid devices.

Conditions

  • Aortic Aneurysm and Dissection

Interventions

  • Thoraflex HybridDevice

    Aortic repair with Thoraflex Hybrid device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary EndpointTime frame: 1 year

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.